Literature DB >> 21570337

CCR2-64I gene polymorphism increase susceptibility to oral cancer.

Mu-Kuan Chen1, Kun-Tu Yeh, Hui-Ling Chiou, Chiao-Wen Lin, Tsung-Te Chung, Shun-Fa Yang.   

Abstract

The purpose of this study was to investigate the impact of MCP-1 and its receptor CCR2 gene polymorphisms on the susceptibility and clinicopathological characteristics of oral cancer, as well as the synergistic effect between these gene polymorphisms and well-known risk factors including alcohol, tobacco, and areca consumptions. Using polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) technique for polymorphism analysis, 344 healthy controls and 216 oral cancer patients were recruited to reveal a significant association between V64I CCR2 gene polymorphism and oral cancer susceptibility. After adjusting for other confounders, individuals with GA (AOR=1.84; 95%CI=1.10-3.20) or at least one A allele (AOR=1.78; 95%CI=1.05-3.02) had a higher risk for oral cancer, compared to GG genotypes. Moreover, results also revealed that for subjects with GA or at least one A allele of V64I CCR2 gene polymorphism, those exposed to environmental risk factors possessed a significantly higher risk for oral cancer than those unexposed subjects. Therefore, genetic polymorphism of CCR2-64I may contribute to the susceptibility to oral cancer.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21570337     DOI: 10.1016/j.oraloncology.2011.04.008

Source DB:  PubMed          Journal:  Oral Oncol        ISSN: 1368-8375            Impact factor:   5.337


  8 in total

Review 1.  CCR2-V64I genetic polymorphism: a possible involvement in HER2+ breast cancer.

Authors:  Bruna Karina Banin-Hirata; Roberta Losi-Guembarovski; Julie Massayo Maeda Oda; Carlos Eduardo Coral de Oliveira; Clodoaldo Zago Campos; Tânia Longo Mazzuco; Sueli Donizete Borelli; Jesus Roberto Ceribelli; Maria Angelica Ehara Watanabe
Journal:  Clin Exp Med       Date:  2015-02-26       Impact factor: 3.984

2.  Impact of MCP-1 and CCR-2 gene polymorphisms on coronary artery disease susceptibility.

Authors:  Hsiu-Ling Lin; Kwo-Chang Ueng; Yih-Shou Hsieh; Whei-Ling Chiang; Shun-Fa Yang; Shu-Chen Chu
Journal:  Mol Biol Rep       Date:  2012-07-03       Impact factor: 2.316

3.  Rs7853346 Polymorphism in lncRNA-PTENP1 and rs1799864 Polymorphism in CCR2 are Associated with Radiotherapy-Induced Cognitive Impairment in Subjects with Glioma Via Regulating PTENP1/miR-19b/CCR2 Signaling Pathway.

Authors:  Sen Yang; Zhan-Zhao Fu; Yan-Qiu Zhang; Bao-Hong Fu; Li-Xin Dong
Journal:  Biochem Genet       Date:  2021-11-19       Impact factor: 2.220

4.  Genetic Variants of lncRNA GAS5 Are Associated with the Clinicopathologic Development of Oral Cancer.

Authors:  Ming-Hong Hsieh; Hsueh-Ju Lu; Chiao-Wen Lin; Chia-Yi Lee; Shang-Jung Yang; Pei-Hsuan Wu; Mu-Kuan Chen; Shun-Fa Yang
Journal:  J Pers Med       Date:  2021-04-26

5.  Association between MCP-1 -2518A/G polymorphism and cancer risk: evidence from 19 case-control studies.

Authors:  Liang-Shan Da; Ying Zhang; Shuai Zhang; Yi-Chun Qian; Qin Zhang; Feng Jiang; Lin Xu
Journal:  PLoS One       Date:  2013-12-18       Impact factor: 3.240

Review 6.  Association of betel nut with carcinogenesis: revisit with a clinical perspective.

Authors:  Rajeshwar N Sharan; Ravi Mehrotra; Yashmin Choudhury; Kamlesh Asotra
Journal:  PLoS One       Date:  2012-08-13       Impact factor: 3.240

7.  Role of Oncofetal Protein CR-1 as a Potential Tumor Marker for Oral Squamous Cell Carcinoma.

Authors:  Anu Jain; Sumanth Kumar Mallupattu; Reetu Thakur; Satyawati Mohindra; Amanjit Bal; Ashim Das; Sushmita Ghoshal; Arnab Pal
Journal:  Indian J Clin Biochem       Date:  2020-06-12

8.  CCL2 Serum Levels and Adiposity Are Associated with the Polymorphic Phenotypes -2518A on CCL2 and 64ILE on CCR2 in a Mexican Population with Insulin Resistance.

Authors:  Milton-Omar Guzmán-Ornelas; Marcelo Heron Petri; Mónica Vázquez-Del Mercado; Efraín Chavarría-Ávila; Fernanda-Isadora Corona-Meraz; Sandra-Luz Ruíz-Quezada; Perla-Monserrat Madrigal-Ruíz; Jorge Castro-Albarrán; Flavio Sandoval-García; Rosa-Elena Navarro-Hernández
Journal:  J Diabetes Res       Date:  2015-12-29       Impact factor: 4.011

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.